Morgan Stanley raised the firm’s price target on Colgate-Palmolive to $93 from $85 and keeps an Overweight rating on the shares. The firm views the company’s Q4 results as “an important confirmation point” that Colgate-Palmolive’s topline growth is poised to inflect compared to peers, the analyst tells investors in a research note. The firm, which also sees 2024 guidance for mid-to-high single digit EPS growth as “clearly too low,” reiterates the stock as its Top Pick in the consumer packaged goods group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CL:
- Colgate-Palmolive price target raised to $91 from $90 at JPMorgan
- Colgate-Palmolive price target raised to $95 from $93 at Citi
- Colgate-Palmolive (NYSE:CL) Gains on Strong Q4 Print
- Options Volatility and Implied Earnings Moves Today, January 26, 2024
- Colgate-Palmolive reports Q4 base gross profit margin up 400 bps to 59.6%